CN1268623C - 组合物和使该组合物稳定的方法 - Google Patents
组合物和使该组合物稳定的方法 Download PDFInfo
- Publication number
- CN1268623C CN1268623C CNB008143137A CN00814313A CN1268623C CN 1268623 C CN1268623 C CN 1268623C CN B008143137 A CNB008143137 A CN B008143137A CN 00814313 A CN00814313 A CN 00814313A CN 1268623 C CN1268623 C CN 1268623C
- Authority
- CN
- China
- Prior art keywords
- compound
- glyceryl ester
- composition
- ester
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CCCCCCC[C@@](C1)[C@@]11C2(CC2)CC(*)C1CC=CCCC*(C)=* Chemical compound CCCCCCC[C@@](C1)[C@@]11C2(CC2)CC(*)C1CC=CCCC*(C)=* 0.000 description 10
- VJZHCLAHAXQPOC-QZMFJGEPSA-N CCCCCC(CC[C@H](C(C)C(C1)OC(C)=O)C1O)(O)O Chemical compound CCCCCC(CC[C@H](C(C)C(C1)OC(C)=O)C1O)(O)O VJZHCLAHAXQPOC-QZMFJGEPSA-N 0.000 description 1
- YNSCXVASUQHUIJ-UCDWSSCISA-N CCCCCCC[C@@H](C1)C1([C@@H](C)C1)C(C2)[C@@H]1OC2O Chemical compound CCCCCCC[C@@H](C1)C1([C@@H](C)C1)C(C2)[C@@H]1OC2O YNSCXVASUQHUIJ-UCDWSSCISA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15954999P | 1999-10-15 | 1999-10-15 | |
| US60/159,549 | 1999-10-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1379769A CN1379769A (zh) | 2002-11-13 |
| CN1268623C true CN1268623C (zh) | 2006-08-09 |
Family
ID=22573018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB008143137A Ceased CN1268623C (zh) | 1999-10-15 | 2000-10-13 | 组合物和使该组合物稳定的方法 |
Country Status (26)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100830061B1 (ko) * | 1999-10-15 | 2008-05-16 | 수캄포 아게 | 이환식 화합물 조성물 및 이의 안정화 방법 |
| US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
| AR037524A1 (es) | 2001-11-14 | 2004-11-17 | Sucampo Ag | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion |
| FR2842810B1 (fr) * | 2002-07-25 | 2006-01-27 | Inst Nat Sciences Appliq | Nouveaux composes gem difluores, leur procedes de preparation et leurs applications. |
| NZ539582A (en) * | 2002-10-23 | 2007-07-27 | Sucampo Ag | Prostaglandin compounds for the treatment of obesity |
| MXPA05006981A (es) * | 2002-12-27 | 2005-12-14 | Sucampo Ag | Derivados de prostaglandinas para el tratamiento de la molestia abdominal. |
| DE602004030245D1 (de) * | 2003-07-03 | 2011-01-05 | Sucampo Ag | Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner |
| TWI348386B (en) * | 2003-08-12 | 2011-09-11 | R Tech Ueno Ltd | Composition and method for promoting hair growth |
| TWI387454B (zh) | 2004-09-02 | 2013-03-01 | Sucampo Ag | 治療胃腸道疾病之方法及組成物 |
| KR20140069182A (ko) * | 2005-04-12 | 2014-06-09 | 수캄포 아게 | 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용 |
| RU2440144C2 (ru) * | 2006-01-24 | 2012-01-20 | Р-Тек Уено, Лтд. | Фармацевтическая композиция, содержащая бициклическое соединение, и способ стабилизации бициклического соединения |
| KR101393944B1 (ko) | 2006-01-24 | 2014-05-12 | 수캄포 아게 | 연질-젤라틴 캡슐 제형물 |
| EP1981867B1 (en) * | 2006-02-07 | 2017-06-14 | R-Tech Ueno, Ltd. | Method for preparing prostaglandin derivative |
| US20090012165A1 (en) | 2007-07-03 | 2009-01-08 | Sucampo Ag | Pharmaceutical combination of nsaid and prostaglandin compound |
| US20090030072A1 (en) | 2007-07-03 | 2009-01-29 | Sucampo Ag | Pharmaceutical combination of opioid and prostaglandin compound |
| AU2008276840B2 (en) * | 2007-07-19 | 2013-10-03 | R-Tech Ueno, Ltd. | Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
| CN101318948B (zh) * | 2008-04-01 | 2011-04-27 | 上海天伟生物制药有限公司 | 鲁比前列酮晶体、其制备方法及用途 |
| US8569279B2 (en) * | 2009-05-27 | 2013-10-29 | Sucampo Ag | Method for modulating claudin mediated functions |
| US20110034424A1 (en) * | 2009-06-30 | 2011-02-10 | Sucampo Ag | Method for the long term nsaid use |
| DK2460801T3 (da) | 2009-07-28 | 2014-09-22 | Ono Pharmaceutical Co | Bicyklisk forbindelse samt anvendelse deraf til medicinske formål |
| MX342548B (es) * | 2009-09-18 | 2016-10-04 | Merck Sharp & Dohme Corp * | Uso del antagonista del receptor opiaceo para los trastornos del tracto gastrointestinal. |
| US8940790B2 (en) | 2009-11-03 | 2015-01-27 | Bernard Charles Sherman | Stable pharmaceutical formulations comprising lubiprostone |
| WO2012102355A1 (ja) * | 2011-01-27 | 2012-08-02 | 小野薬品工業株式会社 | 二環式化合物およびその医薬用途 |
| JP5835236B2 (ja) | 2011-01-27 | 2015-12-24 | 小野薬品工業株式会社 | 二環式化合物およびその医薬用途 |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
| EP3277274B1 (en) | 2015-04-01 | 2024-06-12 | Cedars-Sinai Medical Center | Anti-methanogenic lovastatin analogs or derivatives and uses thereof |
| WO2018003945A1 (ja) | 2016-06-30 | 2018-01-04 | 小野薬品工業株式会社 | 二環式化合物の製造方法 |
| JP6957610B2 (ja) | 2016-10-06 | 2021-11-02 | スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ | 医薬品用途のための多層ビーズ |
| WO2019213330A1 (en) * | 2018-05-01 | 2019-11-07 | Idrop, Inc. | Liquid depot for non-invasive sustained delivery of agents to the eye |
| WO2019221215A1 (ja) * | 2018-05-18 | 2019-11-21 | ニプロ株式会社 | ルビプロストン含有粒子状医薬組成物 |
| JP7518661B2 (ja) * | 2020-05-14 | 2024-07-18 | 沢井製薬株式会社 | ルビプロストン含有整粒物、ルビプロストン含有錠剤およびそれらの製造方法 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US18202A (en) * | 1857-09-15 | Improvement in feathering paddle-wheels | ||
| JPS5720305B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-02-28 | 1982-04-27 | ||
| US4034003A (en) | 1974-04-11 | 1977-07-05 | Ono Pharmaceutical Co., Ltd. | 15-Cycloalkyl-prostaglandins |
| US3966962A (en) | 1975-03-27 | 1976-06-29 | The Upjohn Company | Triacetin solutions of PGE-type compounds |
| JPS5350141A (en) * | 1976-10-18 | 1978-05-08 | Ono Pharmaceut Co Ltd | Stabilization of prostaglandin and prostaglandin analogues |
| JPS5919524B2 (ja) | 1976-12-17 | 1984-05-07 | 中外製薬株式会社 | 安定な１α−ヒドロキシビタミンＤ類含有製剤 |
| JPS5391110A (en) | 1977-01-20 | 1978-08-10 | Yamanouchi Pharmaceut Co Ltd | Novel drug composition for rectal infusion |
| CA1184906A (en) * | 1977-04-19 | 1985-04-02 | Roy A. Johnson | 9-deoxy-5,9-epoxy-prostaglandins |
| JPS6022708B2 (ja) | 1977-07-14 | 1985-06-03 | 小野薬品工業株式会社 | プロスタグランジン類似化合物 |
| JPS5452717A (en) * | 1977-09-29 | 1979-04-25 | Chugai Pharmaceut Co Ltd | Stable oily pharmaceuticals containing 1alpha-hydroxyvitamin d |
| US4130566A (en) | 1977-10-27 | 1978-12-19 | Sumitomo Chemical Company, Limited | Process for producing 5-carboxy-2-acetylthiophene |
| AT358530B (de) | 1978-04-25 | 1980-09-10 | Plc Pharma Licences | Stabilisierungsverfahren |
| JPS55136219A (en) | 1979-04-11 | 1980-10-23 | Sumitomo Chem Co Ltd | Diazepam oily drug |
| US4670569A (en) | 1981-04-02 | 1987-06-02 | G. D. Searle & Co. | 5-fluoro-PGI2 compounds |
| JPS59137413A (ja) * | 1983-01-25 | 1984-08-07 | Teijin Ltd | ７−チアプロスタグランジンｅ↓１類を含有する医薬品組成物 |
| US4579958A (en) | 1983-12-23 | 1986-04-01 | G. D. Searle & Co. | 5-fluoro-3-oxa-6,7-didehydro-PGI1 compounds |
| US4687864A (en) | 1983-12-23 | 1987-08-18 | G. D. Searle & Co. | 5-fluoro-3-oxa-prostacyclin compounds |
| US5225439A (en) | 1987-01-28 | 1993-07-06 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
| US5166174A (en) * | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| US5380709A (en) | 1987-01-28 | 1995-01-10 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
| US4758880A (en) | 1987-03-27 | 1988-07-19 | The Grass Valley Group, Inc. | Video matte generator |
| EP0391909B1 (en) | 1987-09-03 | 1994-08-17 | The University Of Georgia Research Foundation, Inc. | Ocular cyclosporin composition |
| US5317032A (en) * | 1987-10-02 | 1994-05-31 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Prostaglandin cathartic |
| ES2051862T3 (es) | 1987-10-02 | 1994-07-01 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para producir un medicamento que tiene un efecto catartico. |
| JP2597649B2 (ja) † | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
| CA1327524C (en) * | 1988-06-17 | 1994-03-08 | Anjaneyulu Seetharam Tadepalli | Prostaglandins for use in medicine |
| JP2579193B2 (ja) | 1988-07-19 | 1997-02-05 | 小野薬品工業株式会社 | １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体 |
| JPH0745504B2 (ja) * | 1988-07-29 | 1995-05-17 | 株式会社上野製薬応用研究所 | プロスタグランジン前駆体およびその製法 |
| JP2794433B2 (ja) | 1989-02-02 | 1998-09-03 | 丸善製薬株式会社 | 甘草疎水性フラボノイド製剤 |
| US5254588A (en) * | 1989-11-22 | 1993-10-19 | Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo | Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds |
| CA2030344C (en) * | 1989-11-22 | 2000-04-18 | Ryuji Ueno | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds |
| CA2030346C (en) † | 1989-11-22 | 2000-04-11 | Ryuji Ueno | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds |
| CA2030345C (en) | 1989-11-22 | 1998-12-08 | Ryuji Ueno | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
| US5256696A (en) | 1989-11-22 | 1993-10-26 | Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo | Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds |
| CA2041417C (en) | 1990-05-01 | 2002-05-21 | Ryuji Ueno | Treatment of pancreatic disease with 15-keto-prostaglandin compounds |
| JPH0446122A (ja) | 1990-06-13 | 1992-02-17 | Nippon Iyakuhin Kogyo Kk | 活性型ビタミンｄ↓３類含有製剤 |
| CA2046069C (en) | 1990-07-10 | 2002-04-09 | Ryuji Ueno | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds |
| JP2938579B2 (ja) | 1990-12-15 | 1999-08-23 | 株式会社上野製薬応用研究所 | 消化管壁保護剤 |
| US5274130A (en) * | 1991-09-03 | 1993-12-28 | R-Tech Ueno Ltd. | Process for production of prostaglandin intermediates |
| JP2746800B2 (ja) * | 1991-09-03 | 1998-05-06 | 株式会社アールテック・ウエノ | プロスタグランジン中間体の製法 |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| CA2150287C (en) * | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| US5981607A (en) | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
| KR100830061B1 (ko) * | 1999-10-15 | 2008-05-16 | 수캄포 아게 | 이환식 화합물 조성물 및 이의 안정화 방법 |
| US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
| JP4210631B2 (ja) | 2004-06-24 | 2009-01-21 | 株式会社日立製作所 | ブレーキ制御装置 |
-
2000
- 2000-10-13 KR KR1020027004709A patent/KR100830061B1/ko not_active Expired - Lifetime
- 2000-10-13 BR BRPI0014869A patent/BRPI0014869B8/pt not_active IP Right Cessation
- 2000-10-13 AT AT04005836T patent/ATE402925T2/de active
- 2000-10-13 PT PT00966462T patent/PT1220849E/pt unknown
- 2000-10-13 JP JP2001530318A patent/JP4332316B2/ja not_active Expired - Lifetime
- 2000-10-13 RU RU2002112984A patent/RU2695274C3/ru active Protection Beyond IP Right Term
- 2000-10-13 HU HU1300369A patent/HU230484B1/hu not_active IP Right Cessation
- 2000-10-13 MX MXPA02003756A patent/MXPA02003756A/es active IP Right Grant
- 2000-10-13 ES ES00966462T patent/ES2221859T3/es not_active Expired - Lifetime
- 2000-10-13 CZ CZ20021037A patent/CZ303625B6/cs not_active IP Right Cessation
- 2000-10-13 NZ NZ518020A patent/NZ518020A/en not_active IP Right Cessation
- 2000-10-13 WO PCT/JP2000/007109 patent/WO2001027099A2/en active IP Right Grant
- 2000-10-13 CN CNB008143137A patent/CN1268623C/zh not_active Ceased
- 2000-10-13 PT PT04005836T patent/PT1426361E/pt unknown
- 2000-10-13 IL IL14880300A patent/IL148803A0/xx active IP Right Grant
- 2000-10-13 DK DK04005836T patent/DK1426361T4/en active
- 2000-10-13 EP EP00966462A patent/EP1220849B1/en not_active Expired - Lifetime
- 2000-10-13 DK DK00966462T patent/DK1220849T3/da active
- 2000-10-13 HK HK02107337.5A patent/HK1045693B/en not_active IP Right Cessation
- 2000-10-13 AR ARP000105407A patent/AR026046A1/es not_active Application Discontinuation
- 2000-10-13 TR TR2002/01032T patent/TR200201032T2/xx unknown
- 2000-10-13 DE DE60039727T patent/DE60039727D1/de not_active Expired - Lifetime
- 2000-10-13 EP EP04005836.4A patent/EP1426361B2/en not_active Expired - Lifetime
- 2000-10-13 HU HU0203746A patent/HU229547B1/hu not_active IP Right Cessation
- 2000-10-13 AT AT00966462T patent/ATE267189T1/de active
- 2000-10-13 ES ES04005836.4T patent/ES2309410T5/es not_active Expired - Lifetime
- 2000-10-13 CA CA002385732A patent/CA2385732C/en not_active Expired - Lifetime
- 2000-10-13 DE DE60010913T patent/DE60010913T2/de not_active Expired - Lifetime
- 2000-10-13 AU AU76856/00A patent/AU780342B2/en not_active Expired
- 2000-10-13 TW TW089121423A patent/TWI281918B/zh not_active IP Right Cessation
- 2000-10-16 US US09/688,351 patent/US6583174B1/en not_active Expired - Lifetime
-
2002
- 2002-03-21 IL IL148803A patent/IL148803A/en unknown
- 2002-03-22 ZA ZA200202312A patent/ZA200202312B/en unknown
- 2002-04-12 NO NO20021736A patent/NO330258B1/no not_active IP Right Cessation
-
2003
- 2003-03-10 US US10/383,581 patent/US7417067B2/en not_active Expired - Lifetime
-
2004
- 2004-12-24 AU AU2004242503A patent/AU2004242503B2/en not_active Expired
-
2008
- 2008-06-23 US US12/144,000 patent/US8088934B2/en not_active Expired - Lifetime
-
2009
- 2009-05-25 JP JP2009125293A patent/JP2009235079A/ja active Pending
-
2011
- 2011-11-04 US US13/289,386 patent/US8097649B1/en not_active Expired - Lifetime
- 2011-12-27 US US13/337,391 patent/US20120095090A1/en not_active Abandoned
-
2013
- 2013-01-30 AR ARP130100275A patent/AR089848A2/es not_active Application Discontinuation
-
2017
- 2017-08-16 AR ARP170102288A patent/AR109354A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1268623C (zh) | 组合物和使该组合物稳定的方法 | |
| CN1146423C (zh) | 前列腺素产品 | |
| CN1077574C (zh) | 托烷衍生物,其制备和应用 | |
| CN1136217C (zh) | 作为jnk蛋白质激酶抑制剂的4-芳基羟吲哚 | |
| CN1093901A (zh) | 烟霉醇衍生物的稳定药物组合物 | |
| CN1767856A (zh) | 用作c型肝炎病毒蛋白酶抑制剂的药物组合物 | |
| CN1026984C (zh) | 偏端霉素衍生物的制备方法 | |
| CN1237106A (zh) | 含有4,5－环氧吗啡喃衍生物的稳定的药物组合物 | |
| CN1671639A (zh) | 新型联苯大麻素和类似联苯的大麻素 | |
| CN1655776A (zh) | 泻药组合物 | |
| CN1039491C (zh) | 四氢咔唑化合物及其制备方法和应用 | |
| CN1349524A (zh) | 血管紧张肽原酶抑制剂 | |
| CN1314669C (zh) | 2,7－取代的吲哚以及它们作为5－ht6调节剂的用途 | |
| CN1062729A (zh) | 可用作血管紧张肽转化酶抑制剂的含氨基和硝基的三环新化合物 | |
| CN101056633A (zh) | 用于贫血治疗的PI3激酶γ抑制剂 | |
| CN1681783A (zh) | 2,4－取代吲哚和它们作为5－ht6调节剂的用途 | |
| CN1047866A (zh) | N-杂芳基-嘌呤-6-胺的制备方法及其药用 | |
| CN1500085A (zh) | 降低脂质的联苯基甲酰胺 | |
| CN1219132A (zh) | 前列腺素i衍生物缓释制剂 | |
| CN1126990A (zh) | 新的(1-苯基-1-杂环基)烷烃衍生物和作为神经保护剂的应用 | |
| CN1489461A (zh) | 甘油三酸酯降低剂组合物 | |
| CN1301258A (zh) | 苯并n－氧化噁二唑衍生物和它们在治疗心绞痛中的应用 | |
| CN1286686A (zh) | 紫杉烷衍生物 | |
| CN1960974A (zh) | 烷基取代的哌啶衍生物及其作为单胺神经递质再摄取抑制剂的用途 | |
| CN1763027A (zh) | 新抗坏血酸化合物，合成方法及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C35 | Partial or whole invalidation of patent or utility model | ||
| IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20141230 Decision number of declaring invalidation: 24743 Granted publication date: 20060809 |